Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme

South African Medical Journal

Volumn 104, Issue 3, 2014, Pages 228-234

  Madhi, S A ^a,b   Bamford, L ^b,c   Ngcobo, N ^b,c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Millenium development goals; Pneumococcal conjugate vaccine; Public immunisation programme; Rotavirus vaccine; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; DIARRHEA; DISEASE SURVEILLANCE; DRUG EFFICACY; GOVERNMENT; HEALTH CARE FACILITY; HEALTH PROGRAM; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MORTALITY; PNEUMOCOCCAL INFECTION; PNEUMONIA; PROGRAM EFFECTIVENESS; ROTAVIRUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION PROGRAMS; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOUTH AFRICA;

EID: 84894731755     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7597     Document Type: Article

References (39)

1. Simons E, Ferrari M, Fricks J, et al. Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data. Lancet 2012;379(9832):2173-2178. [http://dx.doi.org/10.1016/S0140-6736(12)60522-4]
2. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009;200(Suppl 1):S9-S15. [http://dx.doi.org/10.1086/605025]
3. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 2009;374(9693):893-902. [http://dx.doi.org/10.1016/S0140-6736(09)61204-6]
4. Tate JE, Patel MM, Steele AD, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010;9(4):395-407. [http://dx.doi.org/10.1586/erv.10.17]
5. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381(9875):1405-1416. [http://dx.doi.org/10.1016/S0140-6736(13)60222-6]
6. Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep 2013;62(16):308-311.
7. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007;82(12):93-104.
8. World Health Organization. Rotavirus vaccine: An update. Wkly Epidemiol Rec 2009;84(51-52):533-538.
9. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349(14):1341-1348. [http://dx.doi.org/10.1056/NEJMoa035060]
10. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhoea in African infants. N Engl J Med 2010;362(4):289-298. [http://dx.doi.org/10.1056/NEJMoa0904797]
11. Steele AD, Madhi SA, Louw CE, et al. Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa. Pediatr Infect Dis J 2011;30(2):125-130. [http://dx.doi.org/10.1097/INF.0b013e3181f42db9]
12. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: Use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 2010;126(1):186-190. [http://dx.doi.org/10.1542/peds.2010-1280]
13. Nunes MC, von Gottberg A, de Gouveia L, et al. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: A time series analysis. AIDS 2011;25(4):453-462. [http://dx.doi.org/10.1097/QAD.0b013e328341b7f1]
14. Madhi SA, Adrian P, Kuwanda L, et al. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 2007;25(13):2451-2457. [http://dx.doi.org/10.1016/j.vaccine.2006.09.019]
15. Jones SA, Groome M, Koen A, et al. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PloS One 2013;8(8):e72794. [http://dx.doi.org/10.1371/journal.pone.0072794]
16. Groome MJ, Moon S-S, Velasquez D, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: A randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Org 2014 (In press).
17. UNICEF and WHO, Immunization Summary. A Statistical reference containing data through 2011, 2013 edition. UNICEF, New York. 2013. http://www.unicef.org/videoaudio/PDFs/EN-ImmSumm-2013.pdf (accessed 24 September 2013).
18. Medical Research Council and Department of Health. SA Demographic & Health Survey 1998. Pretoria: Department of Health, 1998. http://www.mrc.ac.za/bod/demographicsurvey.htm (accessed 24 September 2013).
19. Department of Health, Medical Research Council, OrcMacro. South Africa Demographic and Health Survey 2003. Pretoria: Department of Health, 2007. http://www.mrc.ac.za/bod/sadhs.htm (accessed 24 September 2013).
20. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhoea in Mexico. N Engl J Med 2010;362(4):299-305. [http://dx.doi.org/10.1056/NEJMoa0905211]
21. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhoea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 2011;30(1 Suppl):S11-S15. [http://dx.doi.org/10.1097/INF.0b013e3181fefb32]
22. Gastanaduy PA, Sanchez-Uribe E, Esparza-Aguilar M, et al. Effect of rotavirus vaccine on diarrhoea mortality in different socioeconomic regions of Mexico. Pediatrics 2013;131(4):e1115-e1120. [http://dx.doi.org/10.1542/peds.2012-2797]
23. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013;369(2):155-163. [http://dx.doi.org/10.1056/NEJMoa1209165]
24. Cohen C, von Mollendorf C, Naidoo N, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South Africa: A matched case-control study. Presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases, Iguaçu Falls, Brazil, 11-15 March 2012. Abstract 226.
25. Madhi SA, Izu A, Violari A, et al. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and-uninfected infants. Vaccine 2013;31(5):777-783. [http://dx.doi.org/10.1016/j.vaccine.2012.11.076]
26. Madhi SA, Groome M, Zar H, et al. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia in South African HIV-uninfected children: A case control study. Presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases, Iguaçu Falls, Brazil, 11-15 March 2012. Abstract 304.
27. Msimang VM, Page N, Groome MJ, et al. Impact of rotavirus vaccine on childhood diarrhoealhospitalization following introduction into the South African public immunization program. Pediatr Infect Dis J 2013;32(12):1359-1364. [http://dx.doi.org/10.1097/INF.0b013e3182a72fc0]
28. Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity andmortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America-a review. Mem Instit Oswaldo Cruz 2011;106(8):907-911.
29. Von Gottberg A, Cohen C, de Gouveia L, et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine 2013;31(38):4200-4208. [http://dx.doi.org/10.1016/j.vaccine.2013.04.077]
30. Von Gottberg A, Cohen C, de Gouveia L, Quan V, et al. Trends in invasive pneumococcal disease after 7-valent pneumococcal conjugate vaccine introduction in South Africa, 2005-2011. Presented at the8th International Symposium on Pneumococci and Pneumococcal Diseases, Iguaçu Falls, Brazil, 11-15 March 2012. Abstract 272.
31. UNICEF, World Health Organization, World Bank, United Nations. Levels and trends in childmortality: Report 2012. Estimates developed by the UN Inter-agency group for Child MortalityEstimation. New York: UNICEF, 2012. http://www.unicef.org/videoaudio/PDFs/UNICEF_2012_child_mortality_for_web_0904.pdf (accessed 20 June 2013).
32. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: Anupdated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379(9832):2151-2161. [http://dx.doi.org/10.1016/S0140-6736(12)60560-1]
33. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ 2013;91(1):70-74. [http://dx.doi.org/10.2471/BLT.12.106807]
34. Madhi SA, Kuwanda L, Cutland C, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and-uninfected children. Clin Infect Dis 2005;40(10):1511-1518. [http://dx.doi.org/10.1086/429828]
35. Groome MJ, Madhi SA. Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: Potential benefits of rotavirusvaccine. Vaccine 2012;30(Suppl 1):A173-A178. [http://dx.doi.org/10.1016/j.vaccine.2011.08.004]
36. Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J 2000;19(12):1141-1147. [http://dx.doi.org/10.1097/00006454-200012000-00004]
37. Nunes MC, von Gottberg A, de Gouveia L, et al. The impact of antiretroviral treatment on theburden of invasive pneumococcal disease in South African children: A time series analysis. AIDS2011;25(4):453-462. [http://dx.doi.org/10.1097/QAD.0b013e328341b7f1]
38. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359(21):2233-2244. [http://dx.doi.org/10.1056/NEJMoa0800971]
39. United Nations. Source: UNICEF. Pneumonia and diarrhoea. June 2012. http://www.childinfo.org/publications (accessed 20 June 2013).